These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23158402)

  • 1. Identifying major hemorrhage with automated data: results of the Veterans Affairs study to improve anticoagulation (VARIA).
    Jasuja GK; Reisman JI; Miller DR; Berlowitz DR; Hylek EM; Ash AS; Ozonoff A; Zhao S; Rose AJ
    Thromb Res; 2013 Jan; 131(1):31-6. PubMed ID: 23158402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrepancies in identification of major bleeding events in patients taking warfarin.
    Seto AC; Kenyon K; Wittkowsky AK
    Pharmacotherapy; 2008 Sep; 28(9):1098-103. PubMed ID: 18752380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and prognosis of life-threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics.
    White RH; McKittrick T; Takakuwa J; Callahan C; McDonell M; Fihn S
    Arch Intern Med; 1996 Jun; 156(11):1197-201. PubMed ID: 8639014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of pharmacist-managed oral anticoagulation therapy in older veterans.
    Poon IO; Lal L; Brown EN; Braun UK
    J Clin Pharm Ther; 2007 Feb; 32(1):21-9. PubMed ID: 17286786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aniticoagulation in patients following prosthetic heart valve replacement.
    Akhtar RP; Abid AR; Zafar H; Khan JS
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):10-7. PubMed ID: 19262444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential associations of beta-blockers with hemorrhagic events for chronic heart failure patients on warfarin.
    Berlowitz DR; Miller DR; Oliveria SA; Cunningham F; Gomez-Caminero A; Rothendler JA
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):799-807. PubMed ID: 16892457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
    Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing patient-level and site-level anticoagulation control as predictors of adverse events.
    Cancino RS; Hylek EM; Reisman JI; Rose AJ
    Thromb Res; 2014 Apr; 133(4):652-6. PubMed ID: 24502961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH; Wheeldon NM
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.
    Ghaswalla PK; Harpe SE; Tassone D; Slattum PW
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):352-60. PubMed ID: 23089199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.
    Wallvik J; Själander A; Johansson L; Bjuhr O; Jansson JH
    Scand J Prim Health Care; 2007 Jun; 25(2):123-8. PubMed ID: 17497491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of bleeding in patients with nonvalvular atrial fibrillation treated with ximelagatran or warfarin: assessment of incidence, case-fatality rate, time course and sites of bleeding, and risk factors for bleeding.
    Douketis JD; Arneklev K; Goldhaber SZ; Spandorfer J; Halperin F; Horrow J
    Arch Intern Med; 2006 Apr; 166(8):853-9. PubMed ID: 16636210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The outpatient bleeding risk index: validation of a tool for predicting bleeding rates in patients treated for deep venous thrombosis and pulmonary embolism.
    Wells PS; Forgie MA; Simms M; Greene A; Touchie D; Lewis G; Anderson J; Rodger MA
    Arch Intern Med; 2003 Apr; 163(8):917-20. PubMed ID: 12719200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study.
    Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY
    J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial.
    Healey JS; Eikelboom J; Douketis J; Wallentin L; Oldgren J; Yang S; Themeles E; Heidbuchel H; Avezum A; Reilly P; Connolly SJ; Yusuf S; Ezekowitz M;
    Circulation; 2012 Jul; 126(3):343-8. PubMed ID: 22700854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Major bleeding complications in a specialized anticoagulation service.
    Fanikos J; Grasso-Correnti N; Shah R; Kucher N; Goldhaber SZ
    Am J Cardiol; 2005 Aug; 96(4):595-8. PubMed ID: 16098319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for care.
    Aspinall SL; DeSanzo BE; Trilli LE; Good CB
    J Gen Intern Med; 2005 Nov; 20(11):1008-13. PubMed ID: 16307625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of genotype-guided warfarin therapy for anticoagulation in elderly patients with atrial fibrillation.
    Leey JA; McCabe S; Koch JA; Miles TP
    Am J Geriatr Pharmacother; 2009 Aug; 7(4):197-203. PubMed ID: 19766951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle.
    Kucher N; Connolly S; Beckman JA; Cheng LH; Tsilimingras KV; Fanikos J; Goldhaber SZ
    Arch Intern Med; 2004 Oct; 164(19):2176-9. PubMed ID: 15505133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.